找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Metastatic Bone Disease; An Integrated Approa R. Lor Randall Book 2024Latest edition The Editor(s) (if applicable) and The Author(s), under

[复制链接]
查看: 26880|回复: 58
发表于 2025-3-21 18:38:44 | 显示全部楼层 |阅读模式
书目名称Metastatic Bone Disease
副标题An Integrated Approa
编辑R. Lor Randall
视频video
概述Covers all aspects of surgical and medical intervention in metastatic bone disease.Presents biology, work-up, medical therapy, radiation and interventional oncology, and more.Features rich and detaile
图书封面Titlebook: Metastatic Bone Disease; An Integrated Approa R. Lor Randall Book 2024Latest edition The Editor(s) (if applicable) and The Author(s), under
描述.Skeletally related events make up approximately 20% of the cancer care economy. Advances in understanding the pathobiology and better biotargeted therapy and improved surgical technology are occurring continuously. Hundreds of thousands of patients are living longer with ever-increasing tumor burden, but patients can remain siloed in their care as they navigate across subspecialty treatments. This comprehensive text ties it all together around the patient, integrating all aspects of care..Providing an integrated approach to the diagnosis and management of patients with metastatic bone disease (MBD), this revised and expanded text combines discussion of the pathobiology of the disease with the latest oncological and orthopedic treatment modalities. After opening with an examination of the epidemiology and impact of MBD, the biology of bone metastases are discussed, along with considerations of the tissue of origin, evaluation, biopsy andmedical therapy, including metabolic agents and biotargeting. The heart of the book presents oncological approaches (supportive, radiation and interventional) and principles of orthopedic surgical oncology, with subsequent chapters covering specific
出版日期Book 2024Latest edition
关键词Ablation technologies; Biotargeting; Bisphosphonates; Bone cancer; Bone tumor; Cement augmentation; Interv
版次2
doihttps://doi.org/10.1007/978-3-031-52001-3
isbn_softcover978-3-031-52003-7
isbn_ebook978-3-031-52001-3
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

书目名称Metastatic Bone Disease影响因子(影响力)




书目名称Metastatic Bone Disease影响因子(影响力)学科排名




书目名称Metastatic Bone Disease网络公开度




书目名称Metastatic Bone Disease网络公开度学科排名




书目名称Metastatic Bone Disease被引频次




书目名称Metastatic Bone Disease被引频次学科排名




书目名称Metastatic Bone Disease年度引用




书目名称Metastatic Bone Disease年度引用学科排名




书目名称Metastatic Bone Disease读者反馈




书目名称Metastatic Bone Disease读者反馈学科排名




单选投票, 共有 1 人参与投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:22:52 | 显示全部楼层
发表于 2025-3-22 02:26:24 | 显示全部楼层
Book 2024Latest editionrapy and improved surgical technology are occurring continuously. Hundreds of thousands of patients are living longer with ever-increasing tumor burden, but patients can remain siloed in their care as they navigate across subspecialty treatments. This comprehensive text ties it all together around t
发表于 2025-3-22 08:02:35 | 显示全部楼层
发表于 2025-3-22 11:38:15 | 显示全部楼层
发表于 2025-3-22 16:27:39 | 显示全部楼层
Introduction to Multiple Myeloma and Multiple Myeloma Bone Diseasecies (Perrot 2022). There will be an estimated 12,640 deaths from MM in 2022. MM has an incidence of 7.1 per 100,000 in the US per year, with higher incidence among non-Hispanic blacks. The estimated prevalence of the disease as of 2019 was 159,787 [3].
发表于 2025-3-22 18:38:57 | 显示全部楼层
Evaluation of the Patient with Carcinoma of Unknown Origin Metastatic to Boneinoma or to rule out primary bone sarcomas. Patients who present with a displaced pathologic fracture require an urgent diagnostic and treatment plan that does not compromise future treatment options and provides durable skeletal reconstruction.
发表于 2025-3-23 00:04:32 | 显示全部楼层
发表于 2025-3-23 02:41:44 | 显示全部楼层
Tissue Engineered Models to Study Bone Metastasis and Metastatic Bone Diseaseon continues to age, MBD rates are expected to increase, resulting in greater economic burden, lower survival rates, and worse clinical outcomes as resources for treatment become strained. Therefore, there is a direct need for improved clinical treatment to enhance survival rates and improve outcomes.
发表于 2025-3-23 08:30:49 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-13 07:11
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表